Ongoing Clinical Trials in AKI
Open Access
- 1 May 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 7 (5), 861-873
- https://doi.org/10.2215/cjn.12191111
Abstract
AKI is an important public health issue. AKI is a common hospital complication associated with increased in-hospital and long-term mortality, extensive morbidity (including prolonged hospital length of stay), and an estimated annual cost of at least $10 billion in the United States. At present, no specific therapy has been developed to prevent AKI, hasten recovery of kidney function, or abrogate the deleterious systemic effects of AKI. However, recent progress includes establishing a consensus definition of AKI and discovery of novel biomarkers that may allow early detection of AKI. Furthermore, significant insights into the pathophysiology of AKI and its deleterious systemic effects have been gleaned from animal studies. Urgently needed are large, definitive randomized clinical trials testing interventions to prevent and/or treat AKI. This review summarizes and analyzes current ongoing clinical trials registered with clinicaltrials.gov that address prevention or management of AKI. The purpose of this review is to provide a resource for people interested in potential prophylactic and therapeutic approaches to patient care and investigators hoping to plan and execute the next round of randomized clinical trials. Finally, this review discusses research needs that are not addressed by the current clinical trials portfolio and suggests key areas for future research in AKI.Keywords
This publication has 44 references indexed in Scilit:
- Temporal Relationship and Predictive Value of Urinary Acute Kidney Injury Biomarkers After Pediatric Cardiopulmonary BypassJournal of the American College of Cardiology, 2011
- Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac SurgeryJournal of the American Society of Nephrology, 2011
- Randomized, Placebo-controlled Clinical Trial of an Aerosolized β2-Agonist for Treatment of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Predictors of Health Utility among 60-Day Survivors of Acute Kidney Injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network StudyClinical Journal of the American Society of Nephrology, 2010
- Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2009
- Nonrecovery of Kidney Function and Death after Acute on Chronic Renal FailureClinical Journal of the American Society of Nephrology, 2009
- N-Acetylcysteine in the Prevention of Contrast-Induced NephropathyClinical Journal of the American Society of Nephrology, 2008
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Caution Regarding the Use of Pilot Studies to Guide Power Calculations for Study ProposalsArchives of General Psychiatry, 2006
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005